help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2008-0092
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gineste, R.
Right arrow Articles by Staels, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gineste, R.
Right arrow Articles by Staels, B.
Molecular Endocrinology 22 (11): 2433-2447
Copyright © 2008 by The Endocrine Society

Phosphorylation of Farnesoid X Receptor by Protein Kinase C Promotes Its Transcriptional Activity

Romain Gineste, Audrey Sirvent, Réjane Paumelle, Stéphane Helleboid, Alexis Aquilina, Raphaël Darteil, Dean W. Hum, Jean-Charles Fruchart and Bart Staels

GENFIT (R.G., A.S., S.H., A.A., R.D., D.W.H.), 59120 Loos-Lez-Lille, France; Institut Pasteur de Lille (R.P., J.-C.F., B.S.); Département d’Athérosclérose; Institut National de la Santé et de la Recherche Médicale Unité 545 (R.G., R.P., J.-C.F, B.S.); Lille F-59019, France; and Université de Lille 2 (R.P., J.-C.F., B.S.), Faculté de Pharmacie, Faculté de Médecine, Lille F-59006, France

Address all correspondence and requests for reprints to Bart Staels: Unité de Recherche 545 Institut National de la Santé et de la Recherche Médicale, 1 rue du Prof Calmette, Boîte Postale 245 59019 Lille, Cedex, France. E-mail: Bart.Staels{at}pasteur-lille.fr.

The farnesoid X receptor (FXR, NR1H4) belongs to the nuclear receptor superfamily and is activated by bile acids such as chenodeoxycholic acid, or synthetic ligands such as GW4064. FXR is implicated in the regulation of bile acid, lipid, and carbohydrate metabolism. Posttranslational modifications regulating its activity have not been investigated yet. Here, we demonstrate that calcium-dependent protein kinase C (PKC) inhibition impairs ligand-mediated regulation of FXR target genes. Moreover, in a transactivation assay, we show that FXR transcriptional activity is modulated by PKC. Furthermore, phorbol 12-myristate 13-acetate , a PKC activator, induces the phosphorylation of endogenous FXR in HepG2 cells and PKC{alpha} phosphorylates in vitro FXR in its DNA-binding domain on S135 and S154. Mutation of S135 and S154 to alanine residues reduces in cell FXR phosphorylation. In contrast to wild-type FXR, mutant FXRS135AS154A displays an impaired PKC{alpha}-induced transactivation and a decreased ligand-dependent FXR transactivation. Finally, phosphorylation of FXR by PKC promotes the recruitment of peroxisomal proliferator-activated receptor {gamma} coactivator 1{alpha}. In conclusion, these findings show that the phosphorylation of FXR induced by PKC{alpha} directly modulates the ability of agonists to activate FXR.

NURSA Molecule Pages Link:

Nuclear Receptors:   SHP  |  FXRα
Coregulators:   PGC-1
Ligands:   GW4064






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society